We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$467B
AUM Growth
-$17.2B
Cap. Flow
-$1.95B
Cap. Flow %
-0.42%
Top 10 Hldgs %
33.17%
Holding
15,669
New
1,406
Increased
6,433
Reduced
6,116
Closed
1,460

Top Buys

Rank Stock Value
1
ATVI
Activision Blizzard
ATVI
+$980M
2
HUM icon
Humana
HUM
+$637M
3
AAPL icon
Apple
AAPL
+$620M
4
HD icon
Home Depot
HD
+$541M
5
MSFT icon
Microsoft
MSFT
+$539M

Top Sells

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$770M
2
MCD icon
McDonald's
MCD
+$654M
3
CI icon
Cigna
CI
+$498M
4
DLR icon
Digital Realty Trust
DLR
+$430M
5
AMZN icon
Amazon
AMZN
+$429M

Sector Composition

Rank Sector Weight
1 Technology 3.91%
2 Healthcare 3.33%
3 Consumer Discretionary 2%
4 Industrials 1.79%
5 Financials 1.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RELL icon
10126
Richardson Electronics
RELL
$299M
$164K ﹤0.01%
14,968
-12,122
-45% -$156K
MTG icon
10127
PUT
MGIC Investment
MTG
$6.39B
$164K ﹤0.01%
9,800
+8,800
+880% +$150K
CORT icon
10128
PUT
Corcept Therapeutics
CORT
$12.4B
$163K ﹤0.01%
6,000
+2,600
+76% +$75.2K
PPBI
10129
CALL
DELISTED
Pacific Premier Bancorp
PPBI
$163K ﹤0.01%
7,500
+6,900
+1,150% +$159K
LADR
10130
PUT
Ladder Capital
LADR
$1.27B
$163K ﹤0.01%
15,900
+12,500
+368% +$135K
OMEX icon
10131
CALL
Odyssey Marine Exploration
OMEX
$52.9M
$163K ﹤0.01%
43,600
+22,700
+109% +$86K
CLDX icon
10132
Celldex Therapeutics
CLDX
$3.29B
$163K ﹤0.01%
5,925
-84,825
-93% -$2.66M
TRMK icon
10133
PUT
Trustmark
TRMK
$2.8B
$163K ﹤0.01%
7,500
+5,800
+341% +$135K
HNRG icon
10134
CALL
Hallador Energy
HNRG
$762M
$163K ﹤0.01%
11,300
+5,000
+79% +$52.8K
SUPN icon
10135
CALL
Supernus Pharmaceuticals
SUPN
$2.81B
$163K ﹤0.01%
5,900
-4,100
-41% -$125K
CPRX
10136
CALL
DELISTED
Catalyst Pharmaceutical
CPRX
$162K ﹤0.01%
13,900
-34,500
-71% -$461K
RDWR icon
10137
PUT
Radware
RDWR
$1.23B
$162K ﹤0.01%
9,600
+500
+5% +$8.79K
DRVN icon
10138
PUT
Driven Brands
DRVN
$2.13B
$162K ﹤0.01%
12,900
-1,000
-7% -$18.3K
ATNM icon
10139
CALL
Actinium Pharmaceuticals
ATNM
$32.6M
$162K ﹤0.01%
27,400
-12,900
-32% -$85.8K
SRTA
10140
CALL
Strata Critical Medical Inc
SRTA
$522M
$162K ﹤0.01%
62,600
-20,600
-25% -$72.4K
ESTE
10141
PUT
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$162K ﹤0.01%
8,000
-5,800
-42% -$101K
IYJ icon
10142
iShares US Industrials ETF
IYJ
$1.97B
$162K ﹤0.01%
1,604
-22,508
-93% -$2.39M
SFBS
10143
PUT
ServisFirst Bancshares
SFBS
$4.99B
$162K ﹤0.01%
3,100
+1,300
+72% +$68.8K
SOL
10144
CALL
DELISTED
Emeren Group
SOL
$162K ﹤0.01%
52,500
+8,100
+18% +$28.1K
TPB icon
10145
PUT
Turning Point Brands
TPB
$1.75B
$162K ﹤0.01%
7,000
-4,400
-39% -$107K
MCRB icon
10146
CALL
Seres Therapeutics
MCRB
$45.6M
$162K ﹤0.01%
3,395
-3,560
-51% -$272K
TSLS icon
10147
PUT
Direxion Daily TSLA Bear 1X ETF
TSLS
$73.4M
$162K ﹤0.01%
830
+570
+219% +$112K
REVG
10148
CALL
DELISTED
REV Group
REVG
$162K ﹤0.01%
10,100
+300
+3% +$4.1K
THRY icon
10149
PUT
Thryv Holdings
THRY
$96M
$161K ﹤0.01%
8,600
-31,900
-79% -$708K
UYG icon
10150
PUT
ProShares Ultra Financials
UYG
$860M
$161K ﹤0.01%
3,700
-7,500
-67% -$354K
404 405
406
407 408

Similar funds

Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Ken Griffin's Q3 2023 Portfolio in Review

As of Q3 2023, Ken Griffin held 15,669 positions worth $467B, down 3.6% from $484B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Ken Griffin's Q3 2023 filing shows 1,406 new, 6,433 increased, 6,116 reduced and 1,460 closed positions. Its largest new stake was Arm: 3,445,206 shares worth $184M. The largest sale was Invesco QQQ Trust, an estimated $770M.

By sector, the portfolio is most concentrated in Technology at 3.9% of assets, up from 3% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Ken Griffin's largest Q3 2023 buy was Arm: 3,445,206 shares worth $184M.
  • Ken Griffin added most to Activision Blizzard in Q3 2023, an estimated $980M increase.
  • Ken Griffin's biggest Q3 2023 reduction was Invesco QQQ Trust, cutting an estimated $770M.
  • Ken Griffin fully exited Coca-Cola Europacific Partners in Q3 2023, selling an estimated $124M.
  • Ken Griffin's ten largest holdings make up 33% of its $467B portfolio in Q3 2023.
  • Ken Griffin opened 1,406 new positions and closed 1,460 in Q3 2023.
  • Ken Griffin's portfolio value fell 3.6% quarter-over-quarter to $467B.

Based on Citadel Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.